CFI-401870

CFI-401870 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel:
Email: support@targetmol.com
Products Intro: Product Name:CFI-401870;CFI401870;CFI 401870
CAS:1430741-35-7
Package:100 mg;500 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: TargetMol Chemicals Inc.
Tel: +8613564774135
Email: zijue.cai@tsbiochem.com
Products Intro: Product Name:CFI-401870
CAS:1430741-35-7
Package:100mg;2500USD|25mg;1520USD|50mg;1980USD
Company Name: ShangHai Biochempartner Co.,Ltd  
Tel: 177-54423994 17754423994
Email: 2853530910@QQ.com
Products Intro: Product Name:CFI-401870
CAS:1430741-35-7
Purity:98% HPLC LCMS Package:100MG;1G
Company Name: Hangzhou Synstar pharmaceutical Technology CO.,Ltd  
Tel: 0571-85361029
Email: synstar518@163.com
Products Intro: Product Name:CFI-401870
CAS:1430741-35-7
Purity:0.98 Package:500mg、1g、5g、25g
Company Name: Hubei Kele Fine Chemical Co., Ltd  
Tel: 027-59101668 19945030958
Email: 2881924765@qq.com
Products Intro: Product Name:CFI-401870
CAS:1430741-35-7
Purity:98% HPLC Package:5KG;1KG;100g;1g

CFI-401870 manufacturers

  • CFI-401870
  • CFI-401870 pictures
  • $2500.00 / 100mg
  • 2024-10-24
  • CAS:1430741-35-7
  • Min. Order:
  • Purity:
  • Supply Ability: 10g
CFI-401870 Basic information
Product Name:CFI-401870
Synonyms:CFI401870;CFI-401870;1H-Indazole-5-carboxamide, N-[(R)-cyclopropyl-2-pyridinylmethyl]-3-[4-[(3-endo)-3-hydroxy-8-azabicyclo[3.2.1]oct-8-yl]phenyl]-
CAS:1430741-35-7
MF:C30H31N5O2
MW:493.6
EINECS:
Product Categories:
Mol File:1430741-35-7.mol
CFI-401870 Structure
CFI-401870 Chemical Properties
Boiling point 820.2±65.0 °C(Predicted)
density 1.345±0.06 g/cm3(Predicted)
pka13.13±0.46(Predicted)
Safety Information
MSDS Information
CFI-401870 Usage And Synthesis
DescriptionCFI-401870 is a orally bioavailable, potent tyrosine threonine kinase (TTK) Inhibitor (TTK IC50 < 10 nM, HCT116 GI50 < 0.1 μM). CFI-401870 displayed low off-target activity (>500×), and microsomal stability (T(1/2) > 30 min). CFI-401870 recapitulated the phenotype of TTK RNAi, demonstrated in vivo tumor growth inhibition upon oral dosing, and was selected for preclinical evaluation.
CFI-401870 Preparation Products And Raw materials
Tag:CFI-401870(1430741-35-7) Related Product Information